Recent Updates on Subcortical Ischemic Vascular Dementia
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Vascular dementia (VaD) is a history-laden disease entity that dates back to the 19th century when arteriosclerotic brain atrophy due to hardening of the arteries was perceived as the major cause of senile dementia. Its existence had been overshadowed by the emergence of Alzheimer’s disease (AD) in the past century and research on AD dominated the field of dementia. Interest in VaD has been revived in recent years as vascular lesions have been shown to make great contributions to the development of dementia, particularly in the elderly. VaD has now evolved into the concept of vascular cognitive impairment (VCI), which encompasses not only VaD but also AD with cerebrovascular disorder and VCI with no dementia. The concept of VCI is intended to maximize the therapeutic potential in dementia management because the vascular component may be amenable to therapeutic intervention particularly in the early stages of cognitive impairment. Subcortical ischemic vascular dementia (SIVD) is pathologically driven by severe stenosis and the occlusion of small vessels that culminate into white matter ischemia and multiple lacunar infarctions in the subcortical structures. The relatively slow progression of symptoms and clinical manifestations associated with cholinergic deficits often make the differentiation of SIVD from AD difficult. The recent development of in vivo amyloid imaging enabled further pathological breakdown of SIVD into pure SIVD and mixed dementia with subcortical ischemia based on the absence or existence of amyloid pathology in the brain. In this article, the authors reviewed the emerging concepts of VaD/VCI and the clinical manifestations, biomarkers, treatments, and preclinical models of SIVD based on the pathophysiologic mechanisms of the disease.
Abstract
Vascular dementia (VaD) is a history-laden disease entity that dates back to the 19th century when arteriosclerotic brain atrophy due to hardening of the arteries was perceived as the major cause of senile dementia. Its existence had been overshadowed by the emergence of Alzheimer’s disease (AD) in the past century and research on AD dominated the field of dementia. Interest in VaD has been revived in recent years as vascular lesions have been shown to make great contributions to the development of dementia, particularly in the elderly. VaD has now evolved into the concept of vascular cognitive impairment (VCI), which encompasses not only VaD but also AD with cerebrovascular disorder and VCI with no dementia. The concept of VCI is intended to maximize the therapeutic potential in dementia management because the vascular component may be amenable to therapeutic intervention particularly in the early stages of cognitive impairment. Subcortical ischemic vascular dementia (SIVD) is pathologically driven by severe stenosis and the occlusion of small vessels that culminate into white matter ischemia and multiple lacunar infarctions in the subcortical structures. The relatively slow progression of symptoms and clinical manifestations associated with cholinergic deficits often make the differentiation of SIVD from AD difficult. The recent development of in vivo amyloid imaging enabled further pathological breakdown of SIVD into pure SIVD and mixed dementia with subcortical ischemia based on the absence or existence of amyloid pathology in the brain. In this article, the authors reviewed the emerging concepts of VaD/VCI and the clinical manifestations, biomarkers, treatments, and preclinical models of SIVD based on the pathophysiologic mechanisms of the disease.
참고문헌 (68)
- Roman GC., "A historical review of the concept of vascular dementia : lessons from the past for the future. Alzheimer Dis Assoc Disord, 13 Suppl 3", S4-8 (1999)
- Roman GC., "On the history of lacunes, etat crible, and the white matter lesions of vascular dementia", Cerebrovasc Dis, 13(Suppl 2), pp.1~6 (2002)
- Hachinski V., "National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards", Stroke, 37, pp.2220~2241 (2006)
- Farooq MU., "Vascular cognitive impairment", Curr Atheroscler Rep, 15, pp.330~ (2013)
- Pendlebury ST., "Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia : a systematic review and meta-analysis", Lancet Neurol, 8, pp.1006~1018 (2009)
- Knopman DS., "Vascular dementia in a population-based autopsy study", Arch Neurol, 60, pp.569~575 (2003)
- Neuropathology Group., "Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study(MRC CFAS)", Lancet, 357, pp.169~175 (2001)
- White L., "Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants", Ann N Y Acad Sci, 977, pp.9~23 (2002)
- Jin YP., "The reciprocal risks of stroke and cognitive impairment in an elderly population", Alzheimers Dement, 2, pp.171~178 (2006)
- Yu KH., "Cognitive impairment evaluated with Vascular Cognitive Impairment Harmonization Standards in a multicenter prospective stroke cohort in Korea", Stroke, 44, pp.786~788 (2013)
- Pendlebury ST., "Stroke-related dementia : rates, risk factors and implications for future research", Maturitas, 64, pp.165~171 (2009)
- Chui HC., "Subcortical ischemic vascular dementia", Neurol Clin, 25, pp.717~740 (2007)
- Roman GC., "Subcortical ischaemic vascular dementia", Lancet Neurol, 1, pp.426~436 (2002)
- Tolppanen AM., "Incidence of stroke in people with Alzheimer disease : a national register-based approach", Neurology, 80, pp.353~358 (2013)
- Chi NF., "Alzheimer disease and risk of stroke : a population-based cohort study", Neurology, 80, pp.705~711 (2013)
- Lee JH., "Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B", Neurology, 77, pp.18~25 (2011)
- Yoon CW., "Cognitive deficits of pure subcortical vascular dementia vs. Alzheimer disease : PiB-PET-based study", Neurology, 80, pp.569~573 (2013)
- Seo SW., "Clinical significance of microbleeds in subcortical vascular dementia", Stroke, 38, pp.1949~1951 (2007)
- Park JH., "Pathogenesis of cerebral microbleeds : in vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment", Ann Neurol, 73, pp.584~593 (2013)
- Patel B., "Cerebral microbleeds and cognition in patients with symptomatic small vessel disease", Stroke, 44, pp.356~361 (2013)
- Morris JC., "Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia", Arch Neurol, 69, pp.700~708 (2012)
- Sperling RA., "Toward defining the preclinical stages of Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.280~292 (2011)
- Pantoni L., "Cerebral small vessel disease : from pathogenesis and clinical characteristics to therapeutic challenges", Lancet Neurol, 9, pp.689~701 (2010)
- Chui H., "Dementia due to subcortical ischemic vascular disease", Clin Cornerstone, 3, pp.40~51 (2001)
- Arvanitakis Z., "Microinfarct pathology, dementia, and cognitive systems", Stroke, 42, pp.722~727 (2011)
- Vinters HV., "Neuropathologic substrates of ischemic vascular dementia", J Neuropathol Exp Neurol, 59, pp.931~945 (2000)
- Ross R., "The pathogenesis of atherosclerosis : a perspective for the 1990s", Nature, 362, pp.801~809 (1993)
- Ross R., "Atherosclerosis--an inflammatory disease", N Engl J Med, 340, pp.115~126 (1999)
- van Norden AG., "Dementia : alzheimer pathology and vascular factors : from mutually exclusive to interaction", Biochim Biophys Acta, 1822, pp.340~349 (2012)
- Choi SH., "Neurologic signs in relation to cognitive function in subcortical ischemic vascular dementia : a CREDOS(Clinical Research Center for Dementia of South Korea)study", Neurol Sci, 33, pp.839~846 (2012)
- Graham NL., "Distinctive cognitive profiles in Alzheimer’s disease and subcortical vascular dementia", J Neurol Neurosurg Psychiatry, 75, pp.61~71 (2004)
- Fuh JL., "Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia", J Neurol Neurosurg Psychiatry, 76, pp.1337~1341 (2005)
- Looi JC., "Differentiation of vascular dementia from AD on neuropsychological tests", Neurology, 53, pp.670~678 (1999)
- Moon SY., "Impact of white matter changes on activities of daily living in mild to moderate dementia", Eur Neurol, 65, pp.223~230 (2011)
- Chabriat H., "Clinical severity in CADASIL related to ultrastructural damage in white matter : in vivo study with diffusion tensor MRI", Stroke, 30, pp.2637~2643 (1999)
- Matthews PM., "Brain structural and functional connectivity and the progression of neuropathology in Alzheimer’s disease", J Alzheimers Dis, 33(Suppl 1), pp.S163~S172 (2013)
- Kato H., "Statistical parametric analysis of cerebral blood flow in vascular dementia with small-vessel disease using Tc-HMPAO SPECT", Cerebrovasc Dis, 26, pp.556~562 (2008)
- Yang DW., "Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: adaptation of statistical parametric mapping", J Neurol Sci, 203-204, pp.199~205 (2002)
- Shyu WC., "Vascular dementia of Binswanger’s type : clinical, neuroradiological and 99mTc-HMPAO SPET study", Eur J Nucl Med, 23, pp.1338~1344 (1996)
- Johnson KA., "Appropriate use criteria for amyloid PET : a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association", J Nucl Med, 54, pp.476~490 (2013)
- Johnson KA., "Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association", Alzheimers Dement, 9, pp.e-1-16~ (2013)
- Nishio K., "A mouse model characterizing features of vascular dementia with hippocampal atrophy", Stroke, 41, pp.1278~1284 (2010)
- Shibata M., "Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion", Stroke, 38, pp.2826~2832 (2007)
- Lacombe P., "Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy", Stroke, 36, pp.1053~1058 (2005)
- Ruchoux MM., "Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Am J Pathol, 162, pp.329~342 (2003)
- Dubroca C., "Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy", Stroke, 36, pp.113~117 (2005)
- Bjerke M., "Subcortical vascular dementia biomarker pattern in mild cognitive impairment", Dement Geriatr Cogn Disord, 28, pp.348~356 (2009)
- Paraskevas GP., "CSF biomarker profile and diagnostic value in vascular dementia", Eur J Neurol, 16, pp.205~211 (2009)
- Kaerst L, "Cerebrospinal fluid biomarkers in Alzheimer’s disease, vascular dementia and ischemic stroke patients: a critical analysis", J Neurol (2013)
- Jonsson M., "Cerebrospinal fluid biomarkers of white matter lesions-cross-sectional results from the LADIS study", Eur J Neurol, 17, pp.377~382 (2010)
- Skoog I., "A population study on blood-brain barrier function in 85-year-olds : relation to Alzheimer’s disease and vascular dementia", Neurology, 50, pp.966~971 (1998)
- Wallin A., "Blood brain barrier function in vascular dementia", Acta Neurol Scand, 81, pp.318~322 (1990)
- Wallin A., "Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia", Eur Neurol, 44, pp.229~235 (2000)
- Rosenberg GA., "Matrix metalloproteinases in neuroinflammation", Glia, 39, pp.279~291 (2002)
- Adair JC., "Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease", Stroke, 35, pp.e159~e162 (2004)
- Rosenberg GA., "Matrix metalloproteinases and their multiple roles in neurodegenerative diseases", Lancet Neurol, 8, pp.205~216 (2009)
- Rosenberg GA., "White matter damage is associated with matrix metalloproteinases in vascular dementia", Stroke, 32, pp.1162~1168 (2001)
- Wallin A., "Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia", Mech Ageing Dev, 122, pp.1937~1949 (2001)
- Launer LJ., "Microinfarcts, brain atrophy, and cognitive function : the Honolulu Asia Aging Study Autopsy Study", Ann Neurol, 70, pp.774~780 (2011)
- Schneider JA., "Where vascular meets neurodegenerative disease", Stroke, 41, pp.S144~S146 (2010)
- Gorelick PB., "Vascular contributions to cognitive impairment and dementia : a statement for healthcare professionals from the american heart association", american stroke association, 2011, pp.42, 2672~2713
- Pantoni L., "The Scandinavian Multi-Infarct Dementia Trial : a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia", J Neurol Sci, 175, pp.116~123 (2000)
- Pantoni L., "Efficacy and safety of nimodipine in subcortical vascular dementia : a randomized placebo-controlled trial", Stroke, 36, pp.619~624 (2005)
- Pantoni L., "Treatment of vascular dementia : evidence from trials with non-cholinergic drugs", J Neurol Sci, 226, pp.67~70 (2004)
- Gottfries CG., "The neurochemistry of vascular dementia", Dementia, 5, pp.163~167 (1994)
- Erkinjuntti T., "Emerging therapies for vascular dementia and vascular cognitive impairment", Stroke, 35, pp.1010~1017 (2004)
- Dichgans M., "Donepezil in patients with subcortical vascular cognitive impairment : a randomised double-blind trial in CADASIL", Lancet Neurol, 7, pp.310~318 (2008)
- Noh Y., "A New Classification System for Ischemia Using a Combination of Deep and Periventricular White Matter Hyperintensities", J Stroke Cerebrovasc Dis (2013)